• Conference Proceeding

Cost effectiveness of rilpivirine- or efavirenz-based regimens for treatment-naive, HIV-1-infected patients: NHS England and Wales perspective

Citation

Girod, I., Bell, M., Adriaenssen, I., & Knight, C. (2012). Cost effectiveness of rilpivirine- or efavirenz-based regimens for treatment-naive, HIV-1-infected patients: NHS England and Wales perspective. In [13], pp. 71–71. .

Abstract